Beveridge Claire, Lynch Kristle
Dr Beveridge is a fellow and Dr Lynch is an assistant professor of clinical medicine in the Division of Gastroenterology and Hepatology at the University of Pennsylvania in Philadelphia, Pennsylvania.
Gastroenterol Hepatol (N Y). 2020 Mar;16(3):131-138.
Esophagogastric junction outflow obstruction (EGJOO) is an abnormal topographic pattern seen on high-resolution manometry. EGJOO is characterized by an elevated median integrated relaxation pressure with intact or weak peristalsis, thus not meeting the criteria for achalasia. This diagnosis has a female predominance and is associated with varying presenting symptoms. EGJOO can be idiopathic or secondary. It is important to assess for secondary causes, including structural or medication-related ones. Cross-sectional imaging is recommended to rule out secondary causes; however, increasing evidence suggests that esophagogastroduodenoscopy and barium esophagram are usually sufficient. The disease course is variable, with up to three-quarters of patients experiencing spontaneous resolution of symptoms over 6 months. In patients who have mild symptoms, it is reasonable to observe and consider treatment if symptoms persist. Variable response has been seen in small studies with both medical treatment and botulinum toxin injection of the lower esophageal sphincter. For patients with significant symptoms and objective evidence of obstruction on imaging, targeted therapy of the lower esophageal sphincter should be considered via pneumatic dilation or myotomy.
食管胃交界部流出道梗阻(EGJOO)是在高分辨率测压中观察到的一种异常形态模式。EGJOO的特征是中位综合松弛压升高,蠕动完整或减弱,因此不符合贲门失弛缓症的标准。这种诊断以女性居多,并伴有不同的临床表现。EGJOO可为特发性或继发性。评估继发性病因很重要,包括结构性或药物相关病因。建议进行横断面成像以排除继发性病因;然而,越来越多的证据表明,食管胃十二指肠镜检查和钡剂食管造影通常就足够了。病程多变,多达四分之三的患者在6个月内症状会自发缓解。对于症状较轻的患者,观察并在症状持续时考虑治疗是合理的。在关于药物治疗和食管下括约肌肉毒杆菌毒素注射的小型研究中,已观察到不同的反应。对于有明显症状且影像学检查有梗阻客观证据的患者,应考虑通过气囊扩张或肌切开术对食管下括约肌进行靶向治疗。